2142.HK
Price:
$10.56
Market Cap:
$1.12B
HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused on identifying and developing unique antibody-based treatments for a variety of immunological conditions and cancers. The company's pipeline includes several promising assets. In immunology, Batoclimab (HBM9161) is a human monoclonal antibody specifically designed to bind and inhibit the neonatal fragment crystallizable receptor, while Tanfanercept (HBM9036) is under development to address moderate to severe dry eye disease. For oncology, HBM Holdings is advancing various therapies, such as HBM7008, a bispecific antibody targeting tumor-associated antigens, and HBM4003, a human anti-CTLA-4 antibody. Additional canc...[Read more]
Industry
Biotechnology
IPO Date
2020-12-10
Stock Exchange
HKSE
Ticker
2142.HK
According to HBM Holdings Limited’s latest financial reports and current stock price. The company's current Current Ratio is 4.90. This represents a change of 3.37% compared to the average of 4.74 of the last 4 quarters.
The mean historical Current Ratio of HBM Holdings Limited over the last ten years is 5.53. The current 4.90 Current Ratio has changed 8.76% with respect to the historical average. Over the past ten years (40 quarters), 2142.HK's Current Ratio was at its highest in in the June 2021 quarter at 17.31. The Current Ratio was at its lowest in in the June 2018 quarter at 0.
Average
5.53
Median
4.22
Minimum
2.59
Maximum
14.45
Discovering the peaks and valleys of HBM Holdings Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 457.01%
Maximum Annual Current Ratio = 14.45
Minimum Annual Increase = -64.16%
Minimum Annual Current Ratio = 2.59
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 5.17 | 83.12% |
| 2024 | 2.82 | -13.82% |
| 2023 | 3.28 | 17.67% |
| 2022 | 2.79 | -52.53% |
| 2021 | 5.87 | -59.41% |
| 2020 | 14.45 | 457.01% |
| 2019 | 2.59 | -64.16% |
The current Current Ratio of HBM Holdings Limited (2142.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
3.76
5-year avg
3.99
10-year avg
5.53
HBM Holdings Limited’s Current Ratio is greater than Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (0.69), greater than Nanjing Leads Biolabs Co Ltd (2.41), greater than Alphamab Oncology (4.02), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2.66), greater than Lepu Biopharma Co., Ltd. (1.14), greater than InnoCare Pharma Limited (4.21), greater than Keymed Biosciences Inc. (4.83), greater than CStone Pharmaceuticals (3.58), less than Antengene Corporation Limited (4.95), greater than Mabwell-b (1.25),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.69 | $3.74B | |
| 2.41 | $8.14B | |
| 4.02 | $6.95B | |
| 2.66 | $1.24B | |
| 1.14 | $6.39B | |
| 4.21 | $18.70B | |
| 4.83 | $24.38B | |
| 3.58 | $8.03B | |
| 4.95 | $2.00B | |
| 1.25 | $10.75B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HBM Holdings Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HBM Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is HBM Holdings Limited's Current Ratio?
How is the Current Ratio calculated for HBM Holdings Limited (2142.HK)?
What is the highest Current Ratio for HBM Holdings Limited (2142.HK)?
What is the 3-year average Current Ratio for HBM Holdings Limited (2142.HK)?
What is the 5-year average Current Ratio for HBM Holdings Limited (2142.HK)?
How does the current Current Ratio for HBM Holdings Limited (2142.HK) compare to its historical average?